GSK, Merck and Pfizer in Ab&B's sights as biotech files for IPO
3 days ago · China is yet to approve a RSV vaccine, unlike the U.S. which has given the green light to shots from GSK, Moderna and Pfizer, but multiple candidates have reached the clinic …
Pfizer Announces Closing of Joint Venture With GlaxoSmithKline …
Aug 1, 2019 · Pfizer Inc. (NYSE: PFE) today announced the closing of its joint venture with GlaxoSmithKline plc (NYSE: GSK) to combine the parties’ respective consumer healthcare …
GSK, Pfizer RSV Shots Required to Carry Guillain-Barré Syndrome ...
Jan 8, 2025 · A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s Arexvy and Pfizer’s Abrysvo, prompting the …
GSK on top in RSV jab rollout, but is Pfizer closing the gap?
2 days ago · GSK and Pfizer’s full-year financial results show that the former is currently winning the battle for take-up of their rival respiratory syncytial virus (RSV) vaccines, although, there are...
Pfizer to exit GSK consumer health joint venture after spinoff
Jun 1, 2022 · Pfizer plans to sell its shares in a consumer health joint venture with GlaxoSmithKline after the business is spun off into a new standalone corporation called …
GSK and Pfizer's RSV vaccines to carry warnings of neurological ...
Jan 7, 2025 · GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug …
Look out GSK, Pfizer and BioNTech are coming for Shingrix
3 days ago · GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to …
GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief
3 days ago · GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from Pfizer.
Analysis-GSK, Pfizer RSV Vaccine Sales Fall in US as Millions Fewer ...
Oct 8, 2024 · (Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and said it was a once-in-a-lifetime shot for …
FDA adds warning to RSV shots from GSK, Pfizer
Jan 8, 2025 · GSK’s and Pfizer’s vaccines for respiratory syncytial virus must carry labels warning of a possible increased risk of a rare neurological disorder, the Food and Drug Administration …